[HTML] jto.org

[HTML][HTML] OA13. 03 long-term overall survival for patients with malignant pleural mesothelioma on pembrolizumab enrolled in KEYNOTE-028

E Alley, J Lopez, A Santoro, A Morosky, S Saraf… - Journal of Thoracic …, 2017 - jto.org
Background Malignant pleural mesothelioma (MPM) is a highly aggressive cancer with poor
prognosis and limited treatment options after progression on platinum-containing …
被引用次数：15 相关文章

[引用][C] OA13. 03 Long-Term Overall Survival for Patients with Malignant Pleural Mesothelioma on Pembrolizumab Enrolled in KEYNOTE-028

E Alley, J Lopez, A Santoro, A Morosky… - Journal of Thoracic …, 2017 - cir.nii.ac.jp
OA13.03 Long-Term Overall Survival for Patients with Malignant Pleural Mesothelioma on
Pembrolizumab Enrolled in KEYNOTE-028 | CiNii Research CiNii 国立情報学研究所 学術 …